Gregg is an accomplished life science executive officer with nearly 30 years of experience leading finance and operations for both venture-backed start-ups and publicly held companies. Prior to founding Danforth Advisors, he designed and executed financial and corporate development strategies as CFO of ImmunoGen (NASDAQ: IMGN) and Archemix. He previously worked as an investment banker with Adams, Harkness & Hill, where he underwrote financings for and provided buy- and sell-side M&A counsel to biotechnology, medical device and healthcare technology companies. He began his career as a corporate attorney with Gaffin & Krattenmaker, a Boston-based law firm.
Gregg holds a BA from Middlebury College, JD from the University of Pittsburgh School of Law and MBA from Carnegie Mellon University.
Select Achievements
- Involvement in five IPOs and multiple filings, one SPAC merger, numerous private placements and three acquisitions as CFO to client companies
- Built and managed operational departments including finance and accounting, human resources, facilities, corporate communications and information systems